Menstrual Changes Associated with Progestogen‐Only Contraception
- 11 January 1986
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 65 (S134) , 21-27
- https://doi.org/10.3109/00016348609157048
Abstract
Unpredictable disturbance of the menstrual cycle is the major problem associated with use of all progestogen-only methods of contraception. This even occurs with those methods which do not usually suppress ovulation, but the disturbance is generally less severe with lower dosage systems. The commonest changes include amenorrhoea and irregular, scanty and infrequent bleeding, but may sometimes involve episodes of prolonged or frequent spotting or light bleeding. Heavy bleeding is rare. Although some abnormalities of endometrial vascular morphology and function have been identified, the mechanisms of abnormal bleeding are poorly understood. Management centres around effective pretreatment counselling and continued support at follow-up. Sometimes a single course of oestrogen therapy may be helpful. This is safe and effective at stopping a particular episode of bleeding provided that an adequate duration of oestrogen effect is given (eg. an oral 2 to 3 week course or a single intramuscular injection). However, experienced investigators rarely use oestrogens and repeated courses are not recommended. There is clearly a major need for basic research in this area, and for the development of improved systems to minimise the problem.Keywords
This publication has 13 references indexed in Scilit:
- Long-term experience with NorplantR contraceptive implants in FinlandContraception, 1985
- A preliminary study of factors influencing perception of menstrual blood loss volumeAmerican Journal of Obstetrics and Gynecology, 1984
- A survey of different approaches to management of menstrual disturbances in women using injectable contraceptivesContraception, 1983
- Oral Contraceptive Use and the Risk of Endometrial CancerJAMA, 1983
- Oral Contraceptive Use and the Risk of Ovarian CancerPublished by American Medical Association (AMA) ,1983
- Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μg norethisterone (NET) minipillContraception, 1982
- Menstrual Blood Loss with Contraceptive Subdermal Levonorgestrel ImplantsFertility and Sterility, 1981
- Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: Norethisterone oenanthate and medroxyprogesterone acetate: 2. Bleeding patterns and side effectsContraception, 1978
- Definition of the problem - The evolution of human reproductionProceedings of the Royal Society of London. B. Biological Sciences, 1976
- Contraception with d-norgestrei silastic rods. Plasma levels of d-norgestrel and influence on the ovarian functionContraception, 1976